Literature DB >> 32616383

COVID-19 containment measures adopted by Italian Paediatric Oncology and Haematology Association (AIEOP) centres to prevent the virus spread among healthcare providers.

Matteo Amicucci1, Marta Canesi2, Elena Rostagno3, Anna Bergadano4, Clara Badino5, Debora Botta6, Diana Fenicia7, Antonella Longo8, Simone Macchi9, Celeste Ricciardi10, Moreno Crotti Partel11.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32616383      PMCID: PMC7305496          DOI: 10.1016/j.ejon.2020.101791

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.588


× No keyword cloud information.
Sars-CoV-2 (COVID-19) is a new virus that has spread rapidly worldwide. Italy has been heavily affected by this pandemic (Lambertini et al., 2020). Cancer patients who contract COVID-19 infection seem to be at a major risk to severe illness and poor prognosis (Kotecha, 2020). Although children seem less vulnerable to the disease, they are not immune to it. The paediatric onco-haematology population is more at risk of contracting the virus because of its fragility due to immunosuppression (Hrusak et al., 2020). The Italian Ministry of Health issued recommendations about patients affected by malignancies, both for adults and children (Ministero della Salute, 2020). Furthermore, in order to support the clinicians, the Italian Paediatric Oncology and Haematology Association (AIEOP) issued a document containing national recommendations tailored on paediatric patients with cancer (AIEOP, 2020). The AIEOP network includes 48 Italian centres sharing standards of treatment, clinical trials protocols and research projects. In order to provide the measures adopted in different haemato-oncology paediatric centres belonging to the AIEOP network, a nurse-led national survey has been conducted. This survey aims to highlight preventive and control measures to manage COVID-19 infection in AIEOP centres. In this short letter we try to exploit the survey results showing what measures are adopted to prevent the spread of the virus among the operators of the AIEOP centres also considering what is reported in the national AIEOP press release (Table 1 ).
Table 1

COVID-19 containment measures adopted by Italian Paediatric Oncology and Haematology Association (AIEOP) centres to prevent the virus spread among healthcare providers (multi-response questions, n = 36).

Implementation AreaContainment measure adopted (healthcare providers)na%
Personal protective equipment (PPE) Related BehavioursAlcohol-based hand rub available in the common areas2363.9
Chlorine-based disinfectants provision to clean surfaces and environments3083.3
Wearing mask as an essential criterion to enter the facilities2261.1
Wearing gloves as an essential criterion to enter the facilities513.9
Use of thermal scanner for those workers who enter the facilities12.8
Body temperature measured or self-reported at the beginning of every work shift2055.6
Work OrganizationStaff meetings suspended2980.6
Events determining gathering in the workplace suspended or reorganized (i.e. nurses' handover, rest breaks at work)2261.1
Hospital cafeteria closed to professionals1541.7
Hospital canteen closed to professional925
Healthcare holidays or any kind of work permit suspended1233.3
Smart work solutions activated (when possible)1644.4
Pediatric onco-haematology staff moved to COVID-19 units1952.8
FinancialSalary increase or supplementary payments for the frontline medical staff00
TrainingE-learning about PPE1233.3
E-learning about the pandemic1336.1
Health RelatedHome isolation period if positive swabs and no symptoms2877.8
No home isolation period and/or no swabs performed to those healthcare providers without symptoms, even in case of previous direct contact with a COVID-19 confirmed case719.4
Home isolation period and/or swabs performed if no symptoms but direct contact with a COVID-19 confirmed case1130.6
Home isolation period if healthcare providers presented symptoms1644.4
Dedicated phone number to answer COVID-19 related questions from healthcare staff2261.1
DiagnosticSwabs performed to the entire staff822.2
Swabs performed to those healthcare providers who were in contact with a COVID-19 confirmed case, without wearing PPE2055.6
Swabs performed to those healthcare providers who presented symptoms (fever and respiratory symptoms)1438.9
Others (e.g. serological tests)411.1

Multi-response questions.

COVID-19 containment measures adopted by Italian Paediatric Oncology and Haematology Association (AIEOP) centres to prevent the virus spread among healthcare providers (multi-response questions, n = 36). Multi-response questions. All the implemented measures are consistent with the AIEOP national recommendations. Sixty-six percent of the responding centres reported a shortage of PPE and difficulties in supply: this was reported about masks (FFP3 66.7%; FFP2 55.6%, surgical 47.2%) and alcohol-hand rub (52.8%). Interestingly, the majority (83.3%) felt safe in their own work environment and considered their work conditions good enough. The rest of the responders (16.7%) did not answer the question. Staff absenteeism has been analysed and only 16.6% of the responders registered an increased rate: this was related to providers’ illness, the need to care for a relative, fear, or lack of transportation to get the workplace. Medical staff have been asked to report the clinical management of cancer children found positive to COVID-19. The survey showed that in 36.1% of the centres, paediatric oncologists have visited the positive covid cancer children in the dedicated covid units or at home; in 19.1% of the centres, paediatric oncologists have not visited themselves the positive covid cancer children. Lastly, 13.8% of the medical staff used phone or telemedicine for consulting with patients. Despite the non-rigid and uniform management in all centres, only 14 positive onco-haematological children were reported and 35 people including doctors, nurses and other staff confirmed that the measures implemented have been satisfactory. Given the limited literature available, this survey represents an excellent vision of how an unexpected emergency situation could be faced and could be a reference in case of similar events in the future.

Declaration of competing interest

None declared.
  3 in total

1.  Challenges posed by COVID-19 to children with cancer.

Authors:  Rishi S Kotecha
Journal:  Lancet Oncol       Date:  2020-03-25       Impact factor: 41.316

2.  Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment.

Authors:  Ondrej Hrusak; Tomas Kalina; Joshua Wolf; Adriana Balduzzi; Massimo Provenzi; Carmelo Rizzari; Susana Rives; María Del Pozo Carlavilla; Maria E V Alonso; Nerea Domínguez-Pinilla; Jean-Pierre Bourquin; Kjeld Schmiegelow; Andishe Attarbaschi; Pernilla Grillner; Karin Mellgren; Jutte van der Werff Ten Bosch; Rob Pieters; Triantafyllia Brozou; Arndt Borkhardt; Gabriele Escherich; Melchior Lauten; Martin Stanulla; Owen Smith; Allen E J Yeoh; Sarah Elitzur; Ajay Vora; Chi-Kong Li; Hany Ariffin; Alexandra Kolenova; Luciano Dallapozza; Roula Farah; Jelena Lazic; Atsushi Manabe; Jan Styczynski; Gabor Kovacs; Gabor Ottoffy; Maria S Felice; Barbara Buldini; Valentino Conter; Jan Stary; Martin Schrappe
Journal:  Eur J Cancer       Date:  2020-04-07       Impact factor: 9.162

3.  Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective.

Authors:  Matteo Lambertini; Angela Toss; Antonio Passaro; Carmen Criscitiello; Chiara Cremolini; Claudia Cardone; Fotios Loupakis; Giuseppe Viscardi; Icro Meattini; Maria Vittoria Dieci; Roberto Ferrara; Raffaele Giusti; Massimo Di Maio
Journal:  ESMO Open       Date:  2020-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.